Direct cytochemical localization of catalytic subunits dissociated from cAMP-dependent protein kinase in Reuber H-35 hepatoma cells. II. Temporal and spatial kinetics by unknown
Direct Cytochemical Localization of Catalytic
Subunits Dissociated from CAMP-dependent Protein Kinase
in Reuber H-35 Hepatoma Cells . II .
Temporal and Spatial Kinetics
CRAIG V. BYUS and WILLIAM H . FLETCHER
Division of Biomedical Sciences and Department of Biochemistry, University of California,
Riverside, California 92521
ABSTRACT
￿
The activation of cyclic AMP-dependent protein kinase has been found to be the
predominant mode by which cyclic AMP (CAMP) leads to alterations of a large variety of
cellular functions . The activation of the kinase results in the release of the catalytic subunit
which as the free enzyme possesses phosphotransferase activity for a variety of specific protein
substrates . Using a sensitive and specific cytofluorometric technique we monitored the ap-
pearance of free catalytic subunit in Reuber H35 hepatoma cells in culture after incubation
with N 6-1'-O-dibutyryl-cyclic AMP (DBcAMP), 8-bromoadenosine-3':5'-cyclic monophosphate
(8-BrcAMP), and glucagon . The cytochemical method employs the heat-stable inhibitor of the
free catalytic subunit which has been conjugated to fluorescein isothiocyanate (F:PKI) and was
validated as described in the companion paper (Fletcher and Byus . 1982 . J . Cell Biol. 93:719-
726) . Here we studied the temporal and spatial kinetics of the free catalytic subunit following
activation of CAMP-dependent protein kinase by increasing concentrations of DBcAMP,8-
BrcAMP, and glucagon . Under similar conditions protein kinase activation was also assessed
biochemically in H35 cell supernatants by assaying the protein kinase activity ratio . Incubation
of the hepatoma cells with DBcAMP (0.1 mM) led to an increase in the activity ratio from 0.2
in control cultures to a value of nearly 1 .0 within a 1- to 2-h period . During this same period
using the F:PKI probe, a significant increase in cytoplasmic and nucleolar fluorescence indica-
tive of the release of the free catalytic subunit was coincidentally observed . In contrast to the
rapid appearance of catalytic subunit in the cytoplasm and nucleolus of the cell within 5-15
min of the addition of DBcAMP, discernible nucleoplasmic fluorescence did not occur until
after 1 h .
H35 cell cultures incubated with 8-BrcAMP (0.01-1 .0 mM) exhibited a more rapid activation
of the protein kinase measured cytochemically compared to the cells treated with DBcAMP .
Cultures incubated with 8-BrcAMP had significantly increased cytoplasmic and nucleolar
fluorescence compared to unstimulated cells within 1 min of the addition of the analogue and
reached a maximal level within 15 min. By employing a microspectrophotometer a distinct
dose-dependent increase in cellular fluorescence (i.e ., free catalytic subunit) was observed as
the concentration of 8-BrcAMP was increased from 0.01 to 1 .0 mM at 1, 5, 15, and 60 min
following stimulation . The addition of glucagon (10-6 M) to the culture also led to the
activation of CAMP-dependent protein kinase as determined by an increase in the activity ratio .
This increase was paralleled throughout the incubation period by a marked elevation in
cytoplasmic and nucleolar fluorescence . The results reported herein suggest that both cyclic
nucleotide analogues and a polypeptide hormone lead to the activation of CAMP-dependent
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protein kinase in similar intracellular compartments in Reuber H35 hepatoma cells . The
appearance of protein kinase catalytic subunit in the nucleolus also serves to support earlier
reports which suggest a biological role for this enzyme in the nucleus .
Many if not all of the effects of adenosine :3':5' cyclic mono-
phosphate (cAMP) upon the cell are thought to be mediated
by the activation of cAMP-dependent protein kinase (1, 2) .
The holoenzyme of this protein kinase is composed of regula-
tory (R) and catalytic (C) subunits which reversibly dissociate
in the presence of cAMP in the following manner : R2C2 +
4cAMP R2-cAMP4 + 2C . The free catalytic subunit (C) is the
active form of the enzyme and possesses a phosphotransferase
activity for many specific substrates which upon phosphoryla-
tion have altered functions . Essentially, it is the degree of
dissociation of the protein kinase, and the availability of the
free catalytic subunit relative to its protein substrates, that
proscribes the manner in which cAMP and many hormones
alter cellular functions. For this reason the measurement of the
state of activation of cAMP-dependent protein kinase (i.e ., the
determination of the protein kinase activity ratio [3]) has in
many instances proven to be a more accurate and sensitive
measurement of the involvement ofcAMP in a particular cell
process than has assessment of intracellular concentration of
the nucleotide. The accurate determination of the protein
kinase activity ratio has proven to be difficult, however, due to
the rapid equilibrium which exists between the holoenzyme
and the free catalytic and regulatory subunits in cell superna-
tants (4) .
As stated previously, the specific localization of the free
catalytic subunit relative to its protein substrate inside the cell
is of great importance in understanding the regulation by
cAMP of a variety of specific cell processes . Intracellular
compartmentalization of cAMP and protein kinase has been
suggested formany years to play a major role in the specificity
of a cAMP response . The localized accumulation ofcAMP or
catalytic subunit in the nucleus, mitochondria, endoplasmic
reticulum, or membranes has been postulated to mediate the
specific actions ofcAMP in gene regulation (5), growth regu-
lation (6), steroid biosynthesis (7), protein synthesis (8), and
membrane permeability (9) .
We have attempted to determined the temporal and spatial
kinetics of the free catalytic subunit upon activation ofcAMP-
dependent protein kinase . We have employed the fluorescence
cytochemical procedure described previously (10), which
makes use of the fluorescein isothiocyanate-conjugated protein
kinase inhibitor (F:PKI) specific for the catalytic subunit . The
activation of protein kinase has been studied in Reuber H35
cells, a minimal deviation hepatoma cell line, incubated with
a variety of concentrations of cyclic nucleotide analogues and
glucagon . For the first time the intracellular localization ofthe
free catalytic subunit in discrete cellular compartments has
been measured concomitant with the cAMP-dependent protein
kinase activity ratio measured biochemically .
A cloned cell line (#7) derived from Reuber H35 hepatoma was kindly
provided by Dr. WesleyD . Wicks (University ofTennessee) . Cells were grown
in Dulbecco's modified Eagle's medium (DME) with 5% calf serum and5% fetal
calfserum (Gibco Laboratories, Grand Island Biological Co., Grand Island,NY)
and were routinely subcultured once a week bytrypsinization (0.05% trypsin and
0.02% EDTA) . Cells not exceeding twenty passages were used in all experiments.
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Assay for cAMP-dependent Protein
Kinase Activity
The cAMP-dependent protein kinase activity was assayed according to a
modification of the procedure of Cherrington et al. (I1) . Approximately 3 x 106
H35 cells were scraped from the culture dishes in cold Hanks' balanced salt
solution (HBSS) and pelleted at 100g for 30 s . The pellet was sonicated for 2-3
s in 100-200 Al ofice-cold 0.01Msodium phosphate buffer, pH 6.9, containing
5.0 mM EDTA, 0.5 mM isobutyl-methylxanthine (MIX), 75 mM NaCl, and
centrifuged at 20,000 g for 2 min . The supernatant solution was removed and
immediately used as the source of enzyme .
The cAMP-dependent protein kinase activity was determined by measuring
the activity in the presence and absence of exogenouscAMP. The assay mixture
contained 100 pg of mixed calfthymus histone, 0.01M phosphate buffer,pH 6.8,
0.025 M Mg(Ac),, 20mM NaF, r-[ P]-ATP and sufficient unlabeledATP for a
final ATP concentration of 0.15 mM, 0.025 ml of a 1:1 dilution of the original
enzyme extract, and J- cAMP to a final concentration of 5 AM. The reaction was
allowed to proceed for 5 min at 30°C andwas terminated by pipetting 0.05 ml of
the reaction medium onto Whatman 3 MM filters (2.3 cm)(Whatman Inc ., Paper
Div., Clifton, NJ) thatwere immediately placed into 10% cold trichloroacetic acid
and then rinsed two times for20 min in 5% trichloroacetic acid, two times in 95%
ethanol, dried, and counted in an Omnifluor/toluene liquid scintillationcocktail.
The protein kinase activity ratio is expressed as the ratio of kinase activity
measured in the absence of exogenous cAMP (-cAMP) relative to the activity
measured in the presence of additional cAMP (+cAMP) . Changes in the activity
ratio occurred without changes in the total protein kinase activity, and the
addition ofactivatedcharcoal at a concentration of5mg/mlinthehomogenizing
buffer did not alter the control or stimulated activity ratio. In addition to the
assays being performed plus and minus cAMP, the protein kinase activity for
each sample was determined with and without saturating amounts of protein
kinase inhibitor (i.e., -I, -cAMP; +1, -cAMP ; -I,+cAMP; and +I,+cAMP). The
protein kinase activity ratio was based upon only kinase activity which was
blocked by the addition of the inhibitor, i .e ., due to the catalytic subunit of
cAMP-dependent protein kinase. In this regard -25-30% of the protein kinase
activity in the H35 supernatants assayed in the absence of cAMP was not
inhibited by a large excess of kinase inhibitor and thus not due to the catalytic
subunit ofcAMP-dependent protein kinase.
Fluorescent Localization of Protein Kinase
Reuber H35 cells were cultured on#1 glass cover slips (12 x 12 mm) in plastic
culture dishes as described above . The cultures were incubated with DBcAMP,
8-BrcAMP, or glucagon, or appropriate diluent for the times indicated and
prepared forcytochemistry, as described in our companion article (preceding this
one) (10). Briefly, cultures were rinsed for 3 min in 4°C phosphate-buffered
saline (PBS), pH 7.4, then fixed for 15 min in anhydrous acetone at -30°C .
Cover slipswere then rinsed in PBS and covered with 100Al of FITC-conjugated
affinity-purified protein kinase inhibitor (F:PKI; 1.25 lAg/ml). After 48-h incu-
bation at 4°C with theF:PKL preparations were washed twice in cold PBS, then
mounted on glass slides with glycerol:PBS or dehydrated with -30°C acetone
andembedded in entellan (EM Laboratories Inc., Elmsford, NY) .
Pictures were taken with a Leitz-Vario-orthomat with a select field integrating
photometer using a75W HBOUV source anda specificexcitation/barrier (Leitz
K2) Kodak Tri-X film was exposed at ASA 800 developed with D-76 (Kodak)
for 12 min . The exposure time was based on the average of 10 exposures of the
most fluorescent preparation in each protocol. For>20 protocols, 15-s exposures
proved appropriate andwas thus used to obtain all ofthe images presented here.
ALeitz MPVcompact microspectrophotometer was used to quantify fluores-
cence intensity . The size ofthe rectangular probe was calibrated with aneyepiece
reticle. For all ofthe readings done in this article the probe size was set at 5 x 5
AM. The MPV was coupled to a HP97 SI-0computer which wasprogrammed to
control the shutter sequencer to obtain standardized readings of 250 ms each.
The computer also recorded all data. For each data point, no fewer than 50
readings were obtained. Fluorescence quantification was done by one ofus orby
students that were not told the nature ofthe preparations. Random readings were
obtained by following an xy grid pattern using the microscope stage drive.
Whenever the probe aperture overlapped the nucleus andcytoplasm of a cell the
shutter sequencer was activated . All data were analyzed by Duncan's one-way
analysis ofvariance .RESULTS
Determination of the protein kinase activity ratio in hepato-
cytes has been used by numerous investigators (11-15) to
measure the state of activation of cAMP-dependent protein
kinase after stimulation of the cells by cyclic nucleotide ana-
logues and hormones (see Materials and Methods) . When
Reuber H35 hepatoma cells at -50% confluence were incu-
batedwith 0.1 mM DBcAMP,cAMP-dependent protein kinase
was activated maximally within 1 h (Fig . 1) . The addition of
DBcAMP to theH35 cell cultures resulted in an increase in the
activity ratio from 0.2 in control cultures to a value of nearly
1.0, indicating total activation ofthe cAMP-dependent protein
kinase within 1 h. The protein kinase remained activated for
up to 3 h, whereupon the activity ratio began to return to
control levels by 4h. This decrease in the activity ratio between
3 and 4 h is indicative of reassociation of the regulatory and
catalytic subunits due to cellular metabolism of the cyclic
nucleotide analogue and a subsequent fall in intracellular
CAMP levels . In parallel preparations the localization of the
catalytic subunitwas observed employing the direct cytochem-
ical procedure described in the accompanying paper (10) .
Cells of cultures that were treated for 2-4 h with PBS or
with 0.10mM DBcAMP in PBS but were not stained with the
F:PKI probe had negligible fluorescence . Therefore, neither
the fixation method nor the nucleotide analog engendered a
nonspecific fluorescence (10) . When unstimulated cultures
were stained with F:PKI, <5% of the cells exhibited a slight
fluorescence which was restricted to cytoplasm (Fig . 1) . This
corresponds to thebasal stateofactivation ofCAMP-dependent
FIGURE 1
￿
Activation of cAMP-dependent protein kinase and localization of free catalytic subunit in Reuber H35 hepatoma cells
incubated with DBcAMP . (A) The effect of DBcAMP upon the activation of cAMP-dependent protein kinase in Reuber H35
hepatoma cells . At time-zero, DBcAMP dissolved in Hanks' balanced salt solution wasadded to the cultures to a final concentration
of 0.1 mM . The cells were scraped from the culture dishes at the times indicated and the protein kinase activity ratio was
determined in cellular supernatants as described in Materials and Methods . The data are represented as the mean t SE of the
activity ratio determined from five replicate culture dishes at each time following the addition of DBcAMP . Reuber H35 hepatoma
cells were cultured on glass cover slips to ~50% confluence and DBcAMP was added in Hanks' balanced salt solution to a final
concentration of 0.10mM for up to 240 min . For photography theexposure time (15 s) was based on preparations incubated for
240 min with DBcAMP . The cultures were fixed in acetone and incubated with 100 td of F:PKI(1 .25 Ag/ml) as described in Materials
and Methods . The unstimulated cell culture (0) was not incubated with DBcAMP whereas the other preparations were treated
with DBcAMP (0.10 mM) for periods of 15, 60, 120, and 240 min .
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729protein kinase shown which is indicative of the presence of
some free catalytic subunit even in unstimulated cells. In
addition, a modest nucleolar fluorescence was occasionally
observed in these unstimulated, stained preparations .
Within 15 min of the addition ofDBcAMP most of the cells
exhibited a cytoplasmic fluorescence which was greater than
that of the F:PKI control cultures (Fig . 1) . Although the
intensity of cytoplasmic fluorescence was above that of the
control or zero-time group there was a defmite variation among
cells of any given culture and often between cells of a single
cluster. (This heterogeneity of response in protein kinase acti-
vation to DBcAMP is not entirely apparent in Fig. 1, due to
the small number of cells shown in the image.) Nucleoli also
bound the F:PKI probe and, on a single cell basis, their
fluorescence was equivalent to that of cytoplasm after 15 min
in the presence of DBcAMP . The nucleoplasm, however, was
only slightly fluorescent even in those cells in which the
cytoplasm and nucleoli were heavily stained .
With exposure to DBcAMP for 60 min, appreciable amounts
of cAMP-dependent protein kinase were activated in nearly all
of the cells (Fig. 1). The variation in fluorescence intensity
among cells was much reduced from the earlier time periods
but was still a feature. Cytoplasmic and nucleolar fluorescence
remained equivalent but both compartments bound more
F:PKI than cells of the 15-min treatment group. Some cells
seemed to release slightly from the substrate and round up . In
those cases it was difficult to determine which cell compart-
ments were labeled with F:PKI, due to the covering of cyto-
plasm overlying the nucleus .
2 h of exposure to DBcAMP induced cAMP-dependent
protein kinase dissociation in all of the cells, resulting in
cellular fluorescence which was somewhat greater than the
maximum observed after 1 h of stimulation (Fig . 1) . While
cytoplasmic and nucleolar staining were intense after the 2-h
treatment with DBcAMP, nucleoplasmic binding of F:PKI
appeared much greater than at any earlier time.
At the longest time of DBcAMP exposure, 4 h, nearly all
cells exhibited some degree ofcAMP-dependent protein kinase
activation . Cytoplasmic fluorescence was markedly reduced
from that of the 1- or 2-h groups but, as seen in Fig. 1 (240
min) nuclear fluorescence was most striking. Some nuclear
content of free catalytic units had been observed at earlier
times but it was generally minor relative to that of cytoplasm
or nucleoli. At 4 h the reverse was the case. Nucleoli also avidly
bound the F:PKI probe but this was more difficult to discern
due to the intensity of the total nuclear fluorescence . Sodium
butyrate alone (I .0 mM) resulted in no increase in intracellular
fluorescence during this 4-h period of incubation.
The intracellular localization of the free catalytic subunit
was also determined after incubation of the Reuber H35 cells
with another cyclic nucleotide analogue, 8-BrcAMP (Fig. 2).
Cultures treated with 0.1mM8-BrcAMP exhibited a significant
increase in cytoplasmic and nucleolar fluorescence compared
to the unstimulated cultures (zero-time) within 1 min of the
addition of the analogue (Fig . 2) . A marked time-dependent
increase in cytoplasmic and nucleolar fluorescence was ob-
served which reached a maximal level 15 min after treatment
with 8-BrcAMP . The protein kinase activity ratio determined
in parallel preparations also increased to a peak value of 0.85
within 15 min of 0.1mM8-BrcAMP addition (data not shown) .
Total cellular fluorescence was measured in Reuber H35 cell
cultures treated with 0.01, 0.10, and 1 .0 mM 8-BrcAMP em-
ploying the microspectrofluorometer as described in Materials
and Methods. With this procedure both a time- and dose-
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dependent increase in total cellular fluorescence can be ob-
served in the F:PKI-stained H35 cells (Fig . 2) . A distinct
elevation in fluorescence can be detected within 1 min of the
addition ofeither of the three concentrations of8-BrcAMP. As
the concentration of8-BrcAMP was increased from 0.01 to 1.0
mM, a dose-dependent difference in the fluorescence of the
F:PKI-treated hepatoma cells could also be observed at 1, 5,
15, and 60 min (Fig. 2) . In these preparations, cytoplasmic and
nucleolar fluorescence increased coincidentally as the concen-
tration of8-BrcAMP became greater .
In addition to the cyclic nucleotide analogues DBcAMP and
8-BRcAMP, the localization of protein kinase was studied
further in H35 cells incubated with glucagon (Fig. 3) . The
addition of glucagon (10-6 M) to the culture medium resulted
in the activation of cAMP-dependent protein kinase as deter-
mined by an increase in the protein kinase activity ratio (Fig .
3) . The activity ratio reached its maximal value within 10 min
and remained at this level for >60 min.
The intracellular location of the free catalytic subunit dis-
sociated after glucagon stimulation was also determined in
these cells by the F:PKI-procedure (Fig. 3) . Glucagon treat-
ment led to a marked increase in both cytoplasmic and nucleo-
lar fluorescence compared to the unstimulated cells within 1
min of the addition ofthe hormone . Cytoplasmic and nucleolar
fluorescence continued to increase in the H35 cells to its peak
value after <10 min of incubation with glucagon . Nucleo-
plasmic fluorescence could also be observed during this period.
In addition, a distinct dose-dependent appearance of catalytic
subunit after glucagon treatment indicative of protein kinase
activation was observed and quantified with the F:PKI proce-
dure. At the lower doses of glucagon a similar subcellular
distribution of catalytic subunit in the cytoplasm and nucleolus
was observed as in cells stimulated with the higher concentra-
tion of hormone (data not shown) .
DISCUSSION
We have been able to measure the time- and dose-dependent
alterations in the localization of the free catalytic subunit of
cAMP-dependent protein kinase in Reuber H35 cells stimu-
lated with DBcAMP, 8-BrcAMP, or glucagon. The use of
FITC-conjugated inhibitor for this study appears to be
uniquely suited for measuring the activation of the kinase in
that the inhibitor does not bind to the holoenzyme as do all
existing antibodies to the catalytic subunit (24, 25) . The data
presented here show that there is a close correlation between
the biochemical and cytochemical procedures used to monitor
protein kinase activation . Changes in the protein kinase activity
ratio observed following incubation ofthe cells with DBcAMP
and glucagon (Figs . 1 and 3) are quite similar to the time-
dependent alterations in total cellular fluorescence seen with
the F:PKI-procedure (Figs. 1 and 3) . The methods employed
for the determination ofthe activity ratio and for the cytochem-
istry are not, however, without limitations (see reference 4 for
discussion of activity ratio and our accompanying article [10]
for F:PKI procedures); yet the high degree of correlation
between them further add to the validity of employing the
fluorescinated inhibitor for the study of the activation and
intracellular compartmentalization of the catalytic subunit.
More importantly, however, it is now possible to determine in
which discrete cell or compartment of the cell the cAMP-
dependent protein kinase becomes activated . Measurement of
the protein kinase activity ratio only provides informationFIGURE 2
￿
Fluorescent localization of the free catalytic subunit in Reuber H35 hepatoma cells incubated with 8-BrcAMP . Reuber
H35 cells were cultured on glass cover slips to -50% confluence and 8-BrcAMP was added to a final concentration of 0.10mM for
up to 60 min . At the times indicated, the cover slips were removed and prepared for cytochemistry as described in Materials and
Methods and in reference 10 . Photographs were obtained using the 60-min preparation for the standard exposure time (15 s) . The
unstimulated cell culture (0) was not incubated with 8-BrcAMP whereas the remaining cultures were treated with 8-BrcAMP for
periods of 1, 5, 15, and 60 min . (All cultures were stained with 1001LI of the F:PKI (1.25 pg/ml) . In addition to 0.10 mM 8-BrcAMP,
replicate cultures were incubated with 0.01 or 1.0 mM 8-BrcAMP for 1, 5, 15, and 60 min . These cells were also fixed and were
incubated with F:PKI as described in Materials and Methods . The fluorescence intensity (mv) of cells was measured using the
microspectrophotometer as described in Materials and Methods . The data are presented as the mean t SE of the determination of
total cellular fluorescence from 50 cells in each culture (done in duplicate or triplicate) . The "control" in this instance refers to
unstimulated cultures (time-zero), fixed, and treated with F:PKI .
concerning the average degree of kinase activation in a popu-
lation of cells independent of either any variation between
individual cells or intracellular compartmentalization .
In terms of the specific localization of the catalytic subunit
after treatment of the hepatoma cells with either DBcAMP, 8-
BrcAMP, or glucagon, in all cases there appears to be concur-
rent activation of the kinase in the cytoplasm and in the
nucleolus . In the case of glucagon this appearance of cytoplas-
mic and nucleolar fluorescence was quite rapid and could be
observed within 1 min (Fig . 3) . The fluorescence data suggest
a moderate heterogeneity of response of the cells to the low
dose of DBcAMP which is not apparent when the state of
kinase activation is measured biochemically (Fig . 1) . This is
due perhaps to intracellular differences in the level ofesterases
which must remove the butyrate groups from DBcAMP before
the cyclic nucleotide analogue can bind to the regulatory
subunit of the holoenzyme . In this regard, 8-BrcAMP (which
can activate the kinase directly) (2) and glucagon which raises
endogenous cAMP content results in the same general pattern
of intracellular fluorescence discussed above, but in a more
rapid temporal sequence and with a somewhat greater homo-
geneity ofresponse between cells .A marked difference between
8-BreAMP and glucagon in the subcellular distribution of the
free catalytic subunit was not routinely observed in the H35
cells . However, in a number of primary cultured cells more
responsive to polypeptide hormones, hormone treatment
caused a more rapid and intense accumulation of nucleo-
plasmic catalytic subunit than did cyclic nucleotide analogues
(34). These observations support the suggestion that hormones
which activate adenylate cyclase may be capable of leading to
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￿
Fluorescent localization of free catalytic subunits in Reuber H35 hepatoma cells incubated with glucagon . Reuber H35
hepatoma cells were cultured on glass cover slips to -50% confluence and glucagon was added in PBS to a final concentration of
10-e M . At the times indicated, the cover slips were removed and prepared for cytochemistry as described in Materials and
Methods . Photographs were obtained using the 60-min cells for the standard exposure time as described previously . The
unstimulated culture (0) was not incubated with glucagon whereas the remaining cultures were treated with glucagon (10-e M)
for periods of 1, 5, 15, and 60 min . Graphically shown is the effect of glucagon upon the activation of CAMP-dependent protein
kinase in Reuber H35 hepatoma cells . Glucagon dissolved in PBS was added to a final concentration of 10-6 M . The cells were
scraped from the culture dishes at the time indicated and the protein kinase activity ratio was determined in cellular supernatants
as described in Materials and Methods . The data are represented as the mean t SE of the activity ratio determined from five
replicate culture dishes at each time following the addition of glucagon .
the appearance of free catalytic unit in different compartments
of the cell than do cyclic nucleotide analogues that activate
protein kinase directly .
Through the use ofthe microspectrophotometer total cellular
fluorescence indicative of the catalytic subunit was quantified
in several ofour protocols (Fig. 2) . Measurements made in this
manner (see Materials and Methods) of the F:PKI-stained H35
cells also serve to illustrate a similar time course for appearance
of free catalytic subunit following 8-BrcAMP and glucagon as
does the measurement of the protein kinase activity ratio. In
addition through the use of the F:PKI-procedure the distinct
dose-dependent activation of kinase holoenzyme (i.e ., appear-
ance ofthe catalytic subunit) can be measured fluorometrically
and provides quantitative information concerning protein ki-
nase activation at unit cell resolution .
It should be emphasized that little can be concluded from
our data concerning the movement of catalytic subunit . Since
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F:PKI does not bind to the holoenzyme the appearance of
catalytic subunit in a given cellular compartment which is not
fluorescent in unstimulated control preparations might indicate
that (a) the catalytic subunit translocated into this part of the
cell from another location or that (b) activation ofthe holoen-
zyme by CAMP in this compartment led to the release of the
catalytic subunit which can then bind F:PKI .
The translocation or movement of the catalytic subunit has
been studied formany years using biochemical procedures and
various cell fractionation techniques . After activation of
CAMP-dependent protein kinase by hormones or cyclic nucleo-
tide analogues, the catalytic subunit has been shown to appear
in the nucleus in the rat liver (16, 17), porcine ovary (18),
adrenal medulla (19, 20), C6glioma cells (21), and in neuro-
blastoma cells (22) . It has, however, been suggested that in
such studies the positively charged catalytic subunit may be-
come artifactually associated with various subcellular organ-elles during tissue homogenization (23). Although this nonspe-
cific binding has often times been minimized bythe appropriate
choice of nonaqueous or high-ionic-strength buffer it has
proven difficult to show conclusively that the protein kinase in
fact translocated into the nucleus. Specific nuclear and some
nucleolar localization of the catalytic subunit by immunocy-
tochemical techniques has been demonstrated previously (23,
24) and adds further support for a physiological role for the
catalytic subunit in the nucleus .
A marked and rapid increase in nucleolar free catalytic
subunit was consistently observed in the H35 cells which were
incubated with cyclic nucleotide analogues or glucagon (Figs .
1, 2, and 3) . The kinetics of diffusion of macromolecules in
cytoplasm does not preclude the possibility that the catalytic
subunit could translocate within 1 min from the cytoplasm to
the nucleus upon activation of the holoenzyme. However, it is
equally possible that the catalytic subunit may be in the nucleus
or nucleolus of unstimulated cells in a condition in which the
enzyme is not able to bind F:PKI . In this regard, the catalytic
subunit could be present in the nucleus in the holoenzyme
form or tightly bound to chromosomal proteins (potential
substrates) and only becomes capable of binding the inhibitor
when cAMP levels increase . We have observed a large increase
in nucleolar and nuclear catalytic subunit employing the F:PKI
procedure in isolated nuclei purified from rat liver incubated
with 8-BrcAMP (data not shown) . For this reason we suggest
that the rapid appearance of free catalytic subunit in the
nucleus and nucleolus after incubation of the cells with cyclic
nucleotide analogues or glucagon may be due to activation of
protein kinase holoenzyme already present in these subcellular
compartments . Translocation or movement of free catalytic
subunit may also occur from cytoplasm to the nucleus or from
the nucleolus to the nucleoplasm and could be indicative of
the nucleoplasmic fluorescence which occurs following 1-h
incubation with DBcAMP (Fig . 1) .
The fluorescence observed predominantly in the nucleus
after 240-min incubation with DBcAMP is a very consistent
yet surprising observation (Fig . 1) . It can be shown in Fig. 1
that as the DBcAMP is metabolized by the cells the total
soluble protein kinase reassociates and the activity ratio begins
to return to control values. A possible explanation of the
continued presence of free catalytic subunit in the nucleus at
240 min is that nucleoplasmic free catalytic subunit is not able
to reassociate with regulatory subunits as rapidly as the cyto-
plasmic kinase and thus remains capable ofbinding theF:PKI .
A more intriguing observation was the rapid and consistent
appearance of free catalytic subunit in the nucleolus of H35
cells upon activation of cAMP-dependent protein kinase . The
physiological role of the catalytic subunit in the nucleolus
remains unknown . However, there is a large variety of nucleo-
lar proteins which are postulated to have specific functions,
some of which have been shown to be phosphorylated (33) . It
is conceivable that the catalytic subunit could be phosphoryl-
ating any of these proteins and altering their function. The
nucleolus itselfis the location ofribosomalRNA synthesis and
as such is closely involved in the trophic response of a cell or
tissue to hormones or drugs and may also be involved in a
number of cell-cycle specific events. Cyclic AMP has been
known for many years to affect growth processes in both a
positive and negative manner, presumably through the activa-
tion of CAMP-dependent protein kinase (6, 26-28) . In this
regard even the total amount of cellular cAMP-dependent
protein kinase has been reported to change during the cell
cycle (29), cardiac hypertrophy (30), tumor promotion (31),
and steroid hormone treatment (32) . The poorly understood
effects ofcAMP upon cell growth might be explained through
further studies of the nucleolar accumulation of the catalytic
subunit and the subsequent phosphorylation ofspecific nucleo-
lar proteins .
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